Prestige Consumer Healthcare logo
Prestige Consumer Healthcare
PBH | NYSE
Chart Builder DCF Calculator
$48.00
+$1.81 (+3.92%)
At close: Nov 16, 2026, 4:00 PM ET
$48.00
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET

Prestige Consumer Healthcare Company Profile

Company profile explained

Company Profile

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.

Key Executives

Name Position
Ronald Lombardi Chairman, President & Chief Executive Officer
Christine Sacco Chief Financial Officer & Chief Operating Officer
Adel Mekhail Executive Vice President of Marketing & Sales
Dean Siegal Director of Communications
Jose Luis Rosado Senior Vice President of Quality & Regulatory Affairs
Philip David Terpolilli Director of Investor Relations
William C. P'Pool Senior Vice President, General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Aug 14, 2026 8-K Current Report
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Aug 05, 2026 4 Filing
Aug 05, 2026 4 Filing
Aug 05, 2026 4 Filing
Aug 05, 2026 4 Filing
Aug 05, 2026 4 Filing
Jul 15, 2026 8-K Current Report
Jul 09, 2026 8-K/A [Amend] Current Report
View All SEC Filings ➞
Prestige Consumer Healthcare
Prestige Consumer Healthcare logo
Country United States
IPO Date Feb 10, 2005
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 890
CEO Ronald Lombardi

Contact Details

660 White Plains Road Tarrytown, New York 10591 United States

Stock Details

Ticker Symbol PBH
Exchange NYSE
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001295947
CUSIP Number 74112D101
ISIN Number US74112D1019
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.